Edition:
United States

Biotechnology & Medical Research

Page 1

Argenx NV raises about $100 mln gross proceeds with Nasdaq IPO

Wednesday, 17 May 2017 09:57pm EDT

May 17 (Reuters) - Argenx Nv :Says raises about $100 million gross proceeds with Nasdaq IPO.Says sale of 5,865,000 American Depository shares at a price to public of $17.00 per ADS.

Pharming withdraws items related to amendment of articles of association from AGM agenda

Wednesday, 17 May 2017 07:30am EDT

May 17 (Reuters) - PHARMING GROUP NV ::PHARMING ANNOUNCES WITHDRAWAL OF AGENDA ITEMS RELATED TO AMENDMENT OF THE ARTICLES OF ASSOCIATION FROM AGM AGENDA.

Hangzhou Tigermed Consulting raises 630 mln yuan in share private placement

Sunday, 14 May 2017 10:13pm EDT

May 15 (Reuters) - Hangzhou Tigermed Consulting Co Ltd <300347.SZ> ::* Says it issues new shares via private placement and raises about 630 million yuan in total.

Theradiag successful capital increase raising 4 million euros

Friday, 12 May 2017 02:07am EDT

May 12 (Reuters) - THERADIAG SA ::SUCCESSFUL CAPITAL INCREASE, RAISING €4 MILLION.COMPANY HAS SOLD 1,749,563 NEW SHARES WITH PAR VALUE OF €1.70 EACH, AT A PRICE OF €2.30 EACH INCLUDING THE ISSUE PREMIUM, FOR A TOTAL AMOUNT OF €4,023,994.90 AND REPRESENTING 20.21% OF THE COMPANY'S POST-TRANSACTION CAPITAL.

Theradiag announces the launch of a capital increase

Thursday, 11 May 2017 12:21pm EDT

May 11 (Reuters) - THERADIAG SA ::ANNOUNCES THE LAUNCH OF A CAPITAL INCREASE.TRANSACTION WILL BE FOR A MAXIMUM AMOUNT OF €4 MILLION.NEW SHARES WILL RANK FOR DIVIDENDS IMMEDIATELY AND WILL BE ADMITTED TO TRADING ON ALTERNEXT PARIS.ISSUE PRICE TO BE AT LEAST EQUAL TO VOLUME-WEIGHTED AVERAGE PRICE IN FIVE TRADING SESSIONS BEFORE ISSUE PRICE IS SET, MINUS DISCOUNT OF UP TO 20%.FUNDS RAISED TO ENABLE THERADIAG TO FACILITATE AND STEP UP ITS INTERNATIONAL DEVELOPMENT, INCLUDING THE LAUNCH OF BIOCLIA® IN EUROPE.

Inventiva issues 707,900 new ordinary shares - Euronext

Thursday, 11 May 2017 09:48am EDT

May 11 (Reuters) - EURONEXT: :FOLLOWING EXERCISE OF NON LISTED STOCK WARRANTS INVENTIVA SA <<>> ISSUES 707,900 NEW ORDINARY SHARES, WHICH WILL BE LISTED ON EURONEXT PARIS MARKET AS OF MAY 15, 2017 .

Adamas Pharmaceuticals enters into sales agreement with Cowen

Thursday, 11 May 2017 09:10am EDT

May 11 (Reuters) - Adamas Pharmaceuticals Inc :Entered into sales agreement with Cowen and co, relating to potential common stock offering of up to $50 million of its shares.

Wilex successfully completes rights issue

Thursday, 11 May 2017 04:26am EDT

May 11 (Reuters) - WILEX AG ::WILEX AG SUCCESSFULLY COMPLETES RIGHTS ISSUE.GROSS PROCEEDS FROM RIGHTS ISSUE OF ALMOST EUR 5.0 MILLION.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary